Journal Mobile Options
Table of Contents
Vol. 15, No. 3-4, 2012
Issue release date: April 2012

Genetic Service Delivery: Infrastructure, Assessment and Information

Kaye C.I.
To view the fulltext, log in and/or choose pay-per-view option

Individual Users: Register with Karger Login Information

Please create your User ID & Password





Contact Information











I have read the Karger Terms and Conditions and agree.

To view the fulltext, please log in

To view the pdf, please log in

Abstract

Identification of genomic determinants of complex disorders such as cancer, diabetes and cardiovascular disease has prompted public health systems to focus on genetic service delivery for prevention of these disorders, adding to their previous efforts in birth defects prevention and newborn screening. This focus is consistent with previously identified obligations of the public health system as well as the core functions of public health identified by the Institute of Medicine. Models of service delivery include provision of services by the primary care provider in conjunction with subspecialists, provision of services through the medical home with co-management by genetics providers, provision of services in conjunction with disorder-specific treatment centers, and provision of services through a network of genetics clinics linked to medical homes. Whatever the model for provision of genetic services, tools to assist providers include facilities for outreach and telemedicine, information technology, just-in-time management plans, and emergency management tools. Assessment tools to determine which care is best are critical for quality improvement and development of best practices. Because the workforce of genetics providers is not keeping pace with the need for services, an understanding of the factors contributing to this lag is important, as is the development of an improved knowledge base in genomics for primary care providers.



Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Centers for Disease Control and Prevention: Ten great public health achievements – United States, 1900–1999. MMWR Morb Mortal Wkly Rep 1999;48:241–243.
  2. Beskow LM, Khoury MJ, Baker TG, Thrasher JF: The integration of genomics into public health research, policy and practice in the United States. Community Genet 2001;4:2–11.
  3. Kaplan F: Tay-Sachs disease carrier screening: a model for preventing genetic disease. Genet Test 1998;2:271–292.
  4. Daly LE, Kirke PN, Molloy A, Weir DG, Scott JM: Folate levels and neural tube defects. Implications for prevention. JAMA 1995;274:1689–1702.

    External Resources

  5. Seymour CA, Thomason MJ, Chalmers RA, Addison GM, Bain MD, Cockburn F, Littlejohns P, Lord J, Wilcox AH: Newborn screening for inborn errors of metabolism: a systematic review. Health Technol Assess 1997;1:i–iv,1–95.
  6. Azen C, Koch R, Friedman E, Wenz E, Fishler K: Summary of findings from the United States collaborative study of children treated for phenylketonuria. Eur J Pediatr 1996;155(suppl 1):S29–32.
  7. Kaye CI, Laxova R, Livingston JE, Lloyd-Puryear MA, Mann M, McCabe ERB, Therrell BL; Genetics Advisory Committee, National Newborn Screening and Geneitcs Resource Center: Integrating genetic services into public health – guidance for state and territorial programs from the National newborn Screening and Genetics Resource Center (NNSGRC). Community Genet 2001;4:175–196.
  8. Foschi R, Lucenteforte E, Bosetti C, Bertuccio P, Tavoni A, LaVecchia C, Negri E: Family history of cancer and stomach cancer risk. Int J Cancer 2008;123:1429–1432.
  9. Khaw KT, Barrett-Connor E: Family history of heart attack: a modifiable risk factor? Circulation 1986;74:239–244.
  10. Hariri S, Yoon PW, Quresh N, Faldez R, Scheuner M, Khoury MJ: Family history of type 2 diabetes: a population-based screening tool for prevention? Genet Med 2006;8:102–108.
  11. Polychronopoulos P, Gioldasis G, Ellui J, Metallinos IC, Lekka NP, Paschalis C, Papapetropoulos T: Family history of stroke in stroke types and subtypes. J Neurol Sci 2002;195:117–122.
  12. Valdez R, Yoon PW, Qureshi N, Green RF, Khoury MJ: Family history in public health practice: a genomic tool for disease prevention and health promotion. Annu Rev Public Health 2010;31:69–87.
  13. Cheng TL, Cohn RD, Dover GJ: The genetics revolution and primary care pediatrics. JAMA 2008;299:451–453.
  14. Yaeger D, McCallum J, Lewis K, Soslow L, Shah U, Potsic W, Stolle C, Krantz ID: Outcomes of clinical examination and genetic testing of 500 individuals with hearing loss evaluated through a genetics of hearing loss clinic. Am J Med Genet Part A 2006;140:827–836.
  15. Emonts M, Veehoven RH, Wiertsema SP, Houwing-Duistermatt JJ, Walraven V, de Groot R, Hermans PW, Sanders EA: Genetic polymorphisms in immunoresponse genes TNFA, IL6, IL10, and TLR4 are associated with recurrent acute otitis media. Pediatrics 2007;120:814–823.

    External Resources

  16. Patel JA, Nair S, Revai K, Grady J, Saeed K, Matalon R, Block S, Chonmaitree T: Association of proinflammatory cytokine gene polymorphisms with susceptibility to otitis media. Pediatrics 2006;118:2273–2279.
  17. Burke W, Psaty BM: Personalized medicine in the era of genomics. JAMA 2007;298:1682–1684.
  18. Harrell JA, Baker EL; Essential Services Workgroup: The essential services of public health. http://www.health.gov/phfunctions/public.htm (accessed July 17, 2011).
  19. Institute of Medicine: The Future of Public Health. Washington, DC, National Academy Press, 1988.
  20. Maternal and Child Health Bureau, Title V Block Grant Program; guidance and forms for the Title V application and annual report. HRSA, MCHB, Department of Health and Human Services, April, 2000. OMB NO 0915–0172.
  21. Starfield B, Holtzman NA, Roland MO, Sibbald B, Harris R, Harris H: Primary care and genetic services. Health care in evolution. Eur J Public Health 2002;12:51–56.
  22. Emery J, Hayflick S: The challenge of integrating genetic medicine into primary care. BMJ 2001;322:1027–1030.
  23. Weatherall DJ: Single gene disorders or complex traits, lessons from the thalassemias and other monogenic diseases. BMJ 2000;321:1117–1120.
  24. Sia C, Tonniges TF, Osterhus E, Taba S: History of the medical home concept. Pediatrics 2004;113(suppl 5):1473–1478.

    External Resources

  25. Grosse SD, Schechter MS, Kulkarni R, Lloyd-Puryear MA, Strickland B, Trevathan E: Models of comprehensive multidisciplinary care for individuals in the United States with genetic disorders. Pediatrics 2009;123:407–412.
  26. Berg AO, Norris TE: A workforce analysis informing medical school expansion, admissions, support for primary care, curriculum, and research. Ann Fam Med 2006;4(suppl 1):S40–41.

    External Resources

  27. Cystic Fibrosis Foundation guidelines for patient services, evaluation, and monitoring in cystic fibrosis centers. The Cystic Fibrosis Foundation Center Committee and Guidelines Subcommittee. Am J Dis Child 1990;144:1311–1312.
  28. Littlewood JM: Good care for people with cystic fibrosis. Paediatr Respir Rev 2000;1:179–189.
  29. Johnson C, Butler SM, Konstan MW, Morgan W, Wohl ME: Factors influencing outcomes in cystic fibrosis: a center-based analysis. Chest 2003;123:20–27.

    External Resources

  30. Massie J, Curnow L, Gaffney L, Carlin J, Francis I: Declining prevalence of cystic fibrosis since the introduction of newborn screening. Arch Dis Child 2010;95:531–533.

    External Resources

  31. Baker JR, Crudder SO, Riske B, Bias V, Forsberg A: A model for a regional system of care to promote the health and well-being of people with rare chronic genetic disorders. Am J Public Health 2005;95:1910–1916.

    External Resources

  32. Ross J: Perspectives of haemophilia carriers. Haemophilia 2000;6(suppl 1):41–45.

    External Resources

  33. Khair K, Gibson F, Meerabeau l: ‘Just an unfortunate coincidence’: children’s understanding of haemophilia genetics and inheritance. Haemophilia 2011;17:470–475.
  34. Hartley JN, Greenberg CR, Mhanni AA: Genetic counseling in a busy pediatric metabolic practice. J Genet Couns 2011;20:20–22.

    External Resources

  35. Eppich WJ, Brannen M, Hunt EA: Team training: implications for emergency and critical care pediatrics. Curr Opin Pediatr 2008;20:255–260.

    External Resources

  36. Greco K, Anderson G: Redressing policy in cancer genetics; moving toward transdisciplinary teams. PPNP 2002;3:129–139.
  37. Zilliacus EM, Meiser B, Lobb EA, Kirk J, Warwick L, Tucker K: Women’s experience of telehealth cancer genetic counseling. J Genet Couns 2010;19:463–472.

    External Resources

  38. Lea DH, Johnson J, Ellingwood S, Walter A, Patel A, Smith R: Telegenetics in Maine: successful clinical and educational service delivery model developed from a 3-year pilot project. Genet Med 2005;7:21–27.
  39. Therrell BL, Schwartz M, Southard C, Williams D, Hannon WH, Mann MY; PEAS Organizing and Working Groups: Newborn Screening System Performance Evaluation Assessment Scheme (PEAS). Semin Perinatol 2010;34:105–120.

    External Resources

  40. Zellerino BC, Milligan SA, Gray JR, Williams MS, Brooks R: Identification and prioritization of quality indicators in clinical genetics: an international survey. Am J Med Genet C Semin Med Genet 2009;151C:179–190.

    External Resources

  41. Zellerino B, Milligan SA, Brooks R, Freedenberg DL, Collingridge DS, Williams MS: Development, testing, and validation of a patient satisfaction questionnaire for use in the clinical genetics setting. Am J Med Genet C Semin Med Genet 2009;151C:191–199.

    External Resources

  42. Chou A, Au S, Williamlon L, Scheunder M, Whitehead S, Mulvihill J: Developing a comprehensive quality metrics set for genetics service delivery. AcademyHealth Annual Research Conference, Seattle, 2011.
  43. Holland R, Meyers D, Hildebrand C, Bridges AJ, Roach MA, Vogelman B: Creating champions for health care quality and safety. Am J Med Qual 2010;25:102–108.

    External Resources

  44. Cooksey JA, Forte Gaetano, Benkendorf J, Blitzer MG: The state of the medical geneticist workforce: findings of the 2003 survey of American Board of medical Genetics certified geneticists. Genet Med 2005;7:439–443.
  45. Burke W, Emery J: Genetics education for primary-care providers. Nat Rev Genet 2002;3:561–566.
  46. Drury N, Bethea J, Guilbert P, Qureshi N: Genetics support to primary care practitioners – a demonstration project. J Genet Couns 2007;16:583–591.


Pay-per-View Options
Direct payment This item at the regular price: USD 38.00
Payment from account With a Karger Pay-per-View account (down payment USD 150) you profit from a special rate for this and other single items.
This item at the discounted price: USD 26.50